Ptc Therapeutics (PTCT) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $19.4 million.
- Ptc Therapeutics' Other Non-Current Assets fell 2328.22% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 2328.22%. This contributed to the annual value of $20.7 million for FY2024, which is 4288.2% down from last year.
- As of Q3 2025, Ptc Therapeutics' Other Non-Current Assets stood at $19.4 million, which was down 2328.22% from $21.8 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Other Non-Current Assets peaked at $75.2 million during Q1 2021, and registered a low of $19.4 million during Q3 2025.
- Its 5-year average for Other Non-Current Assets is $40.8 million, with a median of $36.2 million in 2023.
- In the last 5 years, Ptc Therapeutics' Other Non-Current Assets skyrocketed by 13356.38% in 2021 and then tumbled by 4873.43% in 2024.
- Over the past 5 years, Ptc Therapeutics' Other Non-Current Assets (Quarter) stood at $46.5 million in 2021, then grew by 4.48% to $48.6 million in 2022, then dropped by 25.39% to $36.2 million in 2023, then crashed by 42.88% to $20.7 million in 2024, then dropped by 6.11% to $19.4 million in 2025.
- Its Other Non-Current Assets was $19.4 million in Q3 2025, compared to $21.8 million in Q2 2025 and $21.4 million in Q1 2025.